CRO issues dampen Ovoca Bio’s trial of female sexual desire drug
14 Jun 2023 //
FIERCE BIOTECH
Statement re Russian Business Operations
07 Mar 2022 //
PRESS RELEASE
Second Price Monitoring Extn
23 Feb 2022 //
INVESTIS
Russian Marketing Authorisation for Orenetide
22 Feb 2022 //
PRESS RELEASE